Patent · US Active

Dioxo-imidazolidine derivatives, which inhibit the enzyme SOAT-1, and pharmaceutical and cosmetic compositions containing them

US8445523B2 · kind B2 · utility

0Cited by
7References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 26, 2010
Grant dateMay 21, 2013
Priority date—
Expiry dateFeb 26, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/107
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

SOAT-1 inhibitors of general formula (I)and cosmetic and pharmaceutical compositions containing such a compound are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.